NasdaqGS - Nasdaq Real Time Price USD

Repare Therapeutics Inc. (RPTX)

1.3600
0.0000
(0.00%)
At close: May 8 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
53,477
53,477
51,133
131,830
7,600
Operating Expense
145,621
145,621
167,357
151,626
116,260
Operating Income
-92,144
-92,144
-116,224
-19,796
-108,660
Net Non Operating Interest Income Expense
10,391
10,391
13,334
5,631
259
Other Income Expense
-1,496
-1,496
-289
265
-185
Pretax Income
-83,249
-83,249
-103,179
-13,900
-108,586
Tax Provision
1,440
1,440
-9,383
15,147
-1,678
Net Income Common Stockholders
-84,689
-84,689
-93,796
-29,047
-106,908
Diluted NI Available to Com Stockholders
-84,689
-84,689
-93,796
-29,047
-106,908
Basic EPS
-2.00
--
-2.23
-0.69
-2.83
Diluted EPS
-2.00
--
-2.23
-0.69
-2.83
Basic Average Shares
42,411.0850
--
42,093.2930
41,922.0420
37,818.1150
Diluted Average Shares
42,411.0850
--
42,093.2930
41,922.0420
37,818.1150
Total Operating Income as Reported
-93,523
-93,523
-116,224
-19,796
-108,660
Total Expenses
145,621
145,621
167,357
151,626
116,260
Net Income from Continuing & Discontinued Operation
-84,689
-84,689
-93,796
-29,047
-106,908
Normalized Income
-83,515.1500
-83,515.1500
-93,641.4596
-29,274.2732
-106,766.2253
Interest Income
10,391
10,391
13,334
5,631
259
Net Interest Income
10,391
10,391
13,334
5,631
259
EBIT
-92,144
-92,144
-116,224
-19,796
-108,660
EBITDA
-90,223
-90,223
-114,273
-17,818
-107,189
Reconciled Depreciation
1,921
1,921
1,951
1,978
1,471
Net Income from Continuing Operation Net Minority Interest
-84,689
-84,689
-93,796
-29,047
-106,908
Total Unusual Items Excluding Goodwill
-1,381
-1,381
-170
308
-144
Total Unusual Items
-1,381
-1,381
-170
308
-144
Normalized EBITDA
-88,842
-88,842
-114,103
-18,126
-107,045
Tax Rate for Calcs
0.0002
0.0002
0.0001
0.0003
0
Tax Effect of Unusual Items
-207.1500
-207.1500
-15.4596
80.7268
-2.2253
12/31/2021 - 6/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HLVX HilleVax, Inc.
1.9100
+3.24%
 
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%
 
EPIX ESSA Pharma Inc.
1.7100
-1.16%
 
KROS Keros Therapeutics, Inc.
14.02
+2.26%
 
IPSC Century Therapeutics, Inc.
0.5200
-0.34%
 
SPRO Spero Therapeutics, Inc.
0.5750
-0.52%
 
KZR Kezar Life Sciences, Inc.
4.1200
+0.98%
 
ASMB Assembly Biosciences, Inc.
11.66
-6.04%
 
PMVP PMV Pharmaceuticals, Inc.
0.8838
-0.67%
 
CLRB Cellectar Biosciences, Inc.
0.2515
+2.99%